Intraday Info: Ampliphi Biosciences Corp (NYSEMKT:APHB) locked on 01/02/2017 at $0.450. It has average volume 550,691 whilst it totals volume 222,916. The company has EPS -2.41 and according to analysts next quarter EPS and next year estimate EPS will -0.30 and -1.06 respectively.
Ownership Summary: Ampliphi Biosciences Corp has total institutional ownership 15.05% while its total outstanding shares 17 millions that’s value of holdings $1 million.
Active Positions: In the latest year, APHB 8 holders have raised its positions while it contains total 530,035 shares. And the strength of reduced positions holders and held positions holders are 6 and 8 respectively.
New and Sold Out Positions: In APHB force of new positions holders 2 and it has total shares 63,981. And force of sold out positions holders 5 and it has 258,584 shares.
Ampliphi Biosciences Corp announced the appointment of Igor P. Bilinsky, Ph.D., as its Senior vp and leader working Officer, effective January 30, 2017. Dr. Bilinsky brings to AmpliPhi nearly many years of enjoy as a lifestyles sciences organization government and consultant, serving public and personal groups. He succeeds Wendy S. Johnson, who served as AmpliPhi’s meantime COO seeing that September 2014 and maintains to serve on AmpliPhi’s board of directors.
“Igor’s wide experience in strategic making plans, operational and entrepreneurial control at biopharmaceutical organizations makes him best to lead operations at AmpliPhi,” said M. Scott Salka, CEO of AmpliPhi Biosciences. “The information he brings to our executive crew will help us attain our formidable plans to deliver a new era of treatments to sufferers plagued through multi-drug resistant bacterial infections. Anyone at AmpliPhi enlarges a heat welcome to Igor.”